Company profile: Proxim Diagnostics
1.1 - Company Overview
Company description
- Provider of next-generation handheld immunodiagnostic solutions, including a portable device for near-patient whole blood testing with touch-screen and multiple connectivity options, low-cost disposable test cartridges, and a test menu for sepsis, cardiology, and infectious disease (e.g., PCT). Suitable for emergency rooms, ICU, nursing and home care, community and employee clinics, rural and remote clinics, disaster relief, and defense.
Products and services
- Disposable Test Cartridge: A low-cost, single-use cartridge engineered for use with Proxim's diagnostic device, enabling a range of laboratory tests across sepsis, cardiology, and infectious disease conditions
- Next-Generation Handheld Immunodiagnostic Device: A portable, custom-engineered device for conducting laboratory tests using whole blood near patients, featuring a touch-screen display and multiple connectivity options
- Test Menu for Sepsis, Cardiology, Infectious Disease: A biomarker-driven menu including tests for sepsis and heart distress, utilizing Procalcitonin (PCT) to differentiate bacterial infection and supporting infectious disease evaluations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Proxim Diagnostics
Retension Pharmaceuticals
HQ: United States
Website
- Description: Provider of healthcare solutions focused on RTN-001, a tissue-targeted PDE5 inhibitor designed to treat hypertension by enhancing nitric oxide action in the central pulmonary vasculature, promoting vasodilation and blood pressure control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Retension Pharmaceuticals company profile →
Verathon
HQ: United States
Website
- Description: Provider of medical devices and services, designing, manufacturing and distributing solutions for airway management and bladder volume measurement, including GlideScope video laryngoscopes, GlideScope Core airway visualization systems, GlideScope Go 2 for EMS, GlideScope Spectrum QC single-use laryngoscopes, BFlex single-use bronchoscopes, and BladderScan ultrasound devices with AI.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verathon company profile →
Aria CV
HQ: United States
Website
- Description: Provider of a medical device in development designed to improve the lives of patients living with pulmonary hypertension.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aria CV company profile →
Procyrion
HQ: United States
Website
- Description: Provider of catheter-based circulatory support technologies, including Aortix, a catheter-deployed pump that augments blood flow from the aortic arch to the lower aorta, reduces aortic root pressure, and increases renal perfusion to support patients with acute decompensated heart failure, renal support needs, and chronic heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Procyrion company profile →
TandemLife
HQ: United States
Website
- Description: Provider of innovative medical device products for cardiologists and cardiac surgeons worldwide, delivering unique solutions for patients requiring circulatory support, including the FDA-cleared TandemHeart System that provides extracorporeal circulatory support in minutes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TandemLife company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Proxim Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Proxim Diagnostics
2.2 - Growth funds investing in similar companies to Proxim Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Proxim Diagnostics
4.2 - Public trading comparable groups for Proxim Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →